- CA$1.73bn
- CA$1.80bn
- CA$647.95m
- 95
- 33
- 88
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.02 | ||
| PEG Ratio (f) | 1.64 | ||
| EPS Growth (f) | 15.55% | ||
| Dividend Yield (f) | 1.06% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.69 | ||
| Price to Tang. Book | 12.86 | ||
| Price to Free Cashflow | 21.96 | ||
| Price to Sales | 2.67 | ||
| EV to EBITDA | 10.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.67% | ||
| Return on Equity | 14.53% | ||
| Operating Margin | 14.82% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 289.99 | 314.34 | 440.12 | 648.42 | 647.95 | 680.93 | 713.59 | 18.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -62.96 | +23.79 | +129.47 | -20.53 | -13.03 | +19.45 | +8.08 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Andlauer Healthcare Group Inc. is a Canada-based supply chain management company. It offers robust platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. Its segments include Specialized Transportation and Healthcare Logistics. The Specialized Transportation segment offers temperature-controlled, as well as non-temperature controlled, ground transportation, air freight forwarding and last mile transportation services to its clients under its ATS Healthcare, ATS Dedicated, Boyle Transportation and Skelton Truck Lines brands. The Healthcare Logistics segment offers logistics and distribution services and packaging solutions to its clients under its Accuristix and LSU brands. It offers services to healthcare manufacturers, wholesalers, distributors and 3PL providers, through its technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products and others.
Directors
- Peter Jelley CHM (48)
- Michael Andlauer CEO (56)
- Peter Bromley CFO
- Stephen Barr CEX
- Bob Brogan CEX
- Reg Sheen CEX
- Ronalee Ambrose LED (51)
- Cameron Joyce DRC (64)
- Joseph Schlett DRC (65)
- Andrew Clark IND (45)
- Evelyn Sutherland IND (47)
- Thomas Wellner IND (56)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 12th, 2019
- Public Since
- December 11th, 2019
- No. of Employees
- 2,290
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 41,323,920
- Address
- 100 Vaughan Valley Blvd., Vaughan, L4H 3C5
- Web
- https://andlauerhealthcare.com/
- Phone
- +1 4167444900
- Auditors
- KPMG LLP
Upcoming Events for AND
Q1 2024 Andlauer Healthcare Group Inc Earnings Call
Andlauer Healthcare Group Inc Annual Shareholders Meeting
Andlauer Healthcare Group Inc Annual Shareholders Meeting
Q2 2024 Andlauer Healthcare Group Inc Earnings Release
Similar to AND
Avant Brands
Toronto Stock Exchange
dentalcorp Holdings
Toronto Stock Exchange
Extendicare
Toronto Stock Exchange
Healwell Al
Toronto Stock Exchange
Medical Facilities
Toronto Stock Exchange
FAQ
What is the Andlauer Healthcare share price?
As of Today at 19:02 UTC, shares in Andlauer Healthcare are trading at CA$41.89. This share price information is delayed by 15 minutes.
How has the Andlauer Healthcare share price performed this year?
Shares in Andlauer Healthcare last closed at CA$41.89 and the price had moved by -17.21% over the past 365 days. In terms of relative price strength the Andlauer Healthcare share price has underperformed the Toronto Stock Exchange 300 Composite Index by -21.44% over the past year.
What are the analyst and broker recommendations for Andlauer Healthcare?
The overall consensus recommendation for Andlauer Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Andlauer Healthcare dividend yield?
The Andlauer Healthcare dividend yield is 0.81% based on the trailing twelve month period.
Does Andlauer Healthcare pay a dividend?
Last year, Andlauer Healthcare paid a total dividend of CA$0.34, and it currently has a trailing dividend yield of 0.81%. We do not have any data on when Andlauer Healthcare is to next pay dividends.
When does Andlauer Healthcare next pay dividends?
We do not have data on when Andlauer Healthcare is to next pay dividends. The historic dividend yield on Andlauer Healthcare shares is currently 0.81%.
How do I buy Andlauer Healthcare shares?
To buy shares in Andlauer Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Andlauer Healthcare?
As of the previous close price of CA$41.89, shares in Andlauer Healthcare had a market capitalisation of CA$1.73bn.
Where are Andlauer Healthcare shares listed?
Here are the trading details for Andlauer Healthcare:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: AND
What kind of share is Andlauer Healthcare?
Based on an overall assessment of its quality, value and momentum Andlauer Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Andlauer Healthcare share price forecast for 2024?
The analyst consensus target price for shares in Andlauer Healthcare is CA$50.93. That is 21.58% above the last closing price of CA$41.89.
Analysts covering Andlauer Healthcare currently have a consensus Earnings Per Share (EPS) forecast of CA$1.86 for the next financial year.
What is the trend in the Andlauer Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Andlauer Healthcare. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -4.55%.
As of the last closing price of CA$41.89, shares in Andlauer Healthcare were trading +2.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Andlauer Healthcare PE Ratio?
The Andlauer Healthcare PE ratio based on its reported earnings over the past 12 months is 22.02. The shares last closed at CA$41.89.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Andlauer Healthcare?
Andlauer Healthcare's management team is headed by:
- Peter Jelley - CHM
- Michael Andlauer - CEO
- Peter Bromley - CFO
- Stephen Barr - CEX
- Bob Brogan - CEX
- Reg Sheen - CEX
- Ronalee Ambrose - LED
- Cameron Joyce - DRC
- Joseph Schlett - DRC
- Andrew Clark - IND
- Evelyn Sutherland - IND
- Thomas Wellner - IND